NIH clinical trial testing antiviral remdesivir plus anti-inflammatory drug baricitinib for COVID-19 begins
08/05/2020
The trial is now enrolling hospitalized adults with COVID-19 in the United States.
The trial is now enrolling hospitalized adults with COVID-19 in the United States.